An international leader in clinical trials, playing a pivotal role in developing new therapies and the advancement of patient care Cancer Trials Australia is the partner of choice, for its members, industry and research organisations, to provide excellence in oncology clinical trials 31 Years ...
Cancer clinical trials in AustraliaNeoplasmsDespite advances in treatment, the greatest gains in cancer control are achieved through prevention.doi:10.5694/j.1326-5377.2011.tb03024.xIan N OlverCancer Council Australia, Sydney, NSW.John Wiley & Sons, LtdMedical Journal of Australia...
R. et al. Lack of concordance in symptomatic adverse event reporting by children, clinicians, and caregivers: implications for cancer clinical trials. J. Clin. Oncol. 40, 1623–1634. (2022). Article CAS PubMed PubMed Central Google Scholar Di Maio, M. et al. The role of patient-...
BARRIERS TO PARTICIPATION IN RANDOMIZED CLINCAL TRIALS FOR EARLY BREAST CANCER AMONG AUSTRALIAN CANCER SPECIALISTS.Examines the efficacy of randomized clinical trials for early breast cancer in Australia. Application of mammography programs; Use of radiotherapy and mastectomy; Implication of high-dose ...
This commenced a new era of clinical trials and the commencement of substantial global collaboration, particularly with the International Breast Cancer Study Group. The Australia New Zealand Group is currently conducting 46 trials encompassing prevention and early and advanced disease. In the Australia ...
Factors that influence clinical trial participation by patients with cancer in Australia: a scoping review protocol. Br Med J Open. 2022;12(4): e057675. Google Scholar Unger JM, Hershman DL, Till C, Minasian LM, Osarogiagbon RU, Fleury ME, et al. “When offered to participate”: a...
The test has yet to be used on humans and large clinical trials are needed before it can be used on prospective patients.
NOVOTECH INITIATES PHASE IB CANCER TRIALS IN AUSTRALIA AND NEW ZEALAND FOR CLIENT, ONCOMED PHARMACEUTICALS Sydney, Australia, 29 October 2010 –Novotech has announced initiation of three Phase Ib oncology trials at sites in Australia and New Zealand to test the safety, efficacy and pharm...
Following thenews of cancer trialsactivated in Australia earlier this week,Aethlon Medical, Inc.(NASDAQ: AEMD) today announced that, on September 9, 2024, the Medanta Institutional Ethics Committee (MIEC) granted full ethics approval for Aethlon's safety, feasibility and dose-finding clinical trial...
"Australia is on track to be the first country to eliminatecervical cancerthrough a combination of immunization, screening and treatment, and our bowel and breast cancer screening programs are among the world's best," Professor Canfell said. "The overseas NELSON trial (Dutch-Belgian) and National...